Micromedic Reports Positive Results On Cancer Detection Trial
By Anouk Lorie December 26, 2012 < 1 minute
Israeli medical diagnostic technology developer Micromedic Technologies Ltd., has announced positive intermediary results in its trial of CellDetect, a technology for detecting cervical cancer. The results show a 94 percent success rate. In light of these results, Micromedic’s share price rose 10.48 percent.
Subscribe to NoCamels weekly newsletter and get our top stories